Patents by Inventor C. J. Su

C. J. Su has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for mycoplasma detection in a biological sample
    Patent number: 5369005
    Abstract: The present invention provides a method for detecting mycoplasma in a biological sample through the application of nucleic acid hybridization techniques. More specifically, the instant invention details a method of detecting a wide variety of mycoplasma in a biological sample by employing a polynucleotide segment encoding a portion of M. pneumoniae P1 polypeptide.
    Type: Grant
    Filed: October 22, 1992
    Date of Patent: November 29, 1994
    Assignee: Board of Regents, The University of Texas System
    Inventors: Joel B. Baseman, C. J. Su, S. F. Dallo
  • Methods and compositions for production of mycoplasmal adhesins
    Patent number: 5281694
    Abstract: The molecular cloning and nucleotide sequence of the complete structural gene encoding Mycoplasma pneumoniae P1 cytadhesin and the amino acid sequence of the protein is described. The present invention provides recombinant DNA clones encoding the complete P1 protein as well as clones expressing P1 polypeptides with cytadhesin epitopes. The substantially purified nucleic acid molecules, recombinant vectors, recombinant cells, and recombinant polypeptides of the present invention are useful as hybridization probes and immunodiagnostic reagents and may be used to prepare anti-mycoplasmal vaccines.
    Type: Grant
    Filed: March 5, 1991
    Date of Patent: January 25, 1994
    Assignee: The University of Texas Board of Regents
    Inventors: Joel B. Baseman, C. J. Su, S. F. Dallo
  • Methods and compositions for production of mycoplasmal adhesins
    Patent number: 5026636
    Abstract: The molecular cloning and nucleotide sequence of the complete structural gene encoding Mycoplasma pneumoniae P1 cytadhesin and the amino acid sequence of the P1 protein is described. The present invention provides recombinant DNA clones encoding the complete P1 protein as well as clones expressing P1 polypeptides with cytadhesin epitopes. The substantially purified nucleic acid molecular recombinant vectors, recombinant cells, and recombinant polypeptides of the present invention are useful as hybridization probes and immunodiagnostic reagents and may be used to prepare anti-mycoplasmal vaccines.
    Type: Grant
    Filed: November 10, 1987
    Date of Patent: June 25, 1991
    Assignee: The University of Texas Board of Regents
    Inventors: Joel B. Baseman, C. J. Su, S. F. Dallo